User profiles for Arthur Wickenhagen

Arthur Wickenhagen

Visiting fellow, Rocky Mountain Laboratories, NIAID, NIH
Verified email at nih.gov
Cited by 1704

A prenylated dsRNA sensor protects against severe COVID-19

A Wickenhagen, E Sugrue, S Lytras, S Kuchi… - Science, 2021 - science.org
INTRODUCTION Interferons (IFNs) are cytokines that are rapidly deployed in response to
invading pathogens. By initiating a signaling cascade that stimulates the expression of …

[HTML][HTML] A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

…, A Merits, S Bakshi, ML Turnbull, A Wickenhagen… - PLoS …, 2021 - journals.plos.org
The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …

Interferon-stimulated gene (ISG)-expression screening reveals the specific antibunyaviral activity of ISG20

J Feng, A Wickenhagen, ML Turnbull, VV Rezelj… - Journal of …, 2018 - Am Soc Microbiol
Bunyaviruses pose a significant threat to human health, prosperity, and food security. In
response to viral infections, interferons (IFNs) upregulate the expression of hundreds of …

[PDF][PDF] Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

…, TI Croll, N Johnson, J Di Iulio, A Wickenhagen… - Cell, 2021 - cell.com
SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

[HTML][HTML] Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore

…, P James, D Stoddart, N Sparks, A Wickenhagen… - BioRxiv, 2020 - ncbi.nlm.nih.gov
Genome sequencing has been widely deployed to study the evolution of SARS-CoV-2 with
more than 90,000 genome sequences uploaded to the GISAID database. We published a …

[HTML][HTML] In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2

…, OA MacLean, RM Pinto, A Wickenhagen… - PLoS …, 2021 - journals.plos.org
Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …

BTN3A3 evasion promotes the zoonotic potential of influenza A viruses

…, M Collados Rodriguez, M Varela, A Wickenhagen… - Nature, 2023 - nature.com
Spillover events of avian influenza A viruses (IAVs) to humans could represent the first step
in a future pandemic 1 . Several factors that limit the transmission and replication of avian …

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity

…, L Tong, E Cameroni, N Johnson, A Wickenhagen… - BioRxiv, 2020 - biorxiv.org
SARS-CoV-2 can mutate to evade immunity, with consequences for the efficacy of emerging
vaccines and antibody therapeutics. Herein we demonstrate that the immunodominant …

[HTML][HTML] Human cytomegalovirus evades ZAP detection by suppressing CpG dinucleotides in the major immediate early 1 gene

…, D McCormick, A Raper, A Wickenhagen… - PLoS …, 2020 - journals.plos.org
The genomes of RNA and small DNA viruses of vertebrates display significant suppression
of CpG dinucleotide frequencies. Artificially increasing dinucleotide frequencies results in …

[HTML][HTML] The antiviral state has shaped the CpG composition of the vertebrate interferome to avoid self-targeting

AE Shaw, SJ Rihn, N Mollentze, A Wickenhagen… - PLoS …, 2021 - journals.plos.org
Antiviral defenses can sense viral RNAs and mediate their destruction. This presents a
challenge for host cells since they must destroy viral RNAs while sparing the host mRNAs that …